204 related articles for article (PubMed ID: 8658295)
1. Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective?
Meyer MP; Haworth C; McNeill L
S Afr Med J; 1996 Mar; 86(3):251-3. PubMed ID: 8658295
[TBL] [Abstract][Full Text] [Related]
2. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.
Shireman TI; Hilsenrath PE; Strauss RG; Widness JA; Mutnick AH
Arch Pediatr Adolesc Med; 1994 Jun; 148(6):582-8. PubMed ID: 8193681
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
6. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
Dallman PR
Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
[No Abstract] [Full Text] [Related]
7. Current controversies in the management of the anemia of prematurity.
Bishara N; Ohls RK
Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
9. Recombinant erythropoietin in anemia of prematurity: five years later.
Shannon K
Pediatrics; 1993 Oct; 92(4):614-7. PubMed ID: 8414840
[No Abstract] [Full Text] [Related]
10. Anaemia of prematurity. Epidemiology, management and costs.
Meyer MP
Pharmacoeconomics; 1997 Oct; 12(4):438-45. PubMed ID: 10174310
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
Kumar P; Shankaran S; Krishnan RG
J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of neonatal anemia with recombinant human erythropoietin: a cost-benefit analysis].
Schefels J; Merz U; Hörnchen H
Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():1-5. PubMed ID: 10612190
[TBL] [Abstract][Full Text] [Related]
14. Financial impact of the introduction of erythropoietin in the treatment of anemia of premature infants in Israel.
Dollberg S; Mimouni FB
Isr Med Assoc J; 1999 Oct; 1(2):86-8. PubMed ID: 10731302
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity.
Pathak A; Roth P; Piscitelli J; Johnson L
Arch Dis Child Fetal Neonatal Ed; 2003 Jul; 88(4):F324-8. PubMed ID: 12819167
[TBL] [Abstract][Full Text] [Related]
16. Resource implications of adopting a restrictive neonatal blood transfusion policy.
Harrison MC; Pillay S; Joolay Y; Rhoda N; Raban MS; Horn AR; Tooke L
S Afr Med J; 2013 Sep; 103(12):916-7. PubMed ID: 24300628
[TBL] [Abstract][Full Text] [Related]
17. Low doses of recombinant erythropoietin in the treatment of anaemia of prematurity.
Latini G; Rosati E; Del Vecchio A
Acta Paediatr; 2001 Jul; 90(7):825-6. PubMed ID: 11519992
[No Abstract] [Full Text] [Related]
18. Use of epoetin (erythropoietin) in the anemia of prematurity.
Novick D; Moore TB; Feig SA
West J Med; 1995 Apr; 162(4):355-6. PubMed ID: 7747503
[No Abstract] [Full Text] [Related]
19. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant erythropoietin and early preterm neonatal anemia].
Piasetskaia NM
Lik Sprava; 1999 Jun; (4):47-51. PubMed ID: 10476641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
